|
Delayed
Australian S.E.
20:01:43 2026-09-28 EDT
|
5-day change | 1st Jan Change | ||
| 2.070 AUD | +1.47% |
|
-3.29% | -24.26% |
| 09-24 | Sector Update: Healthcare Stocks Advance Late Afternoon | MT |
| 09-24 | Mesoblast Limited Receives FDA Approval for New Potency Assay to Release Commercial Ryoncil Product | CI |
| Market Cap | 2.65B 1.86B 1.64B 1.55B 1.4B 2.63B 178B 18.51B 7.15B 91.06B 6.98B 6.83B 293B | P/E 2027 * |
-147x | P/E 2028 * | 18.3x |
|---|---|---|---|---|---|
| Enterprise Value | 2.75B 1.93B 1.7B 1.6B 1.45B 2.73B 185B 19.2B 7.41B 94.42B 7.24B 7.08B 303B | EV / Sales 2027 * |
10.3x | EV / Sales 2028 * | 6.55x |
| Free-Float |
63.68% | Yield 2027 * |
-
| Yield 2028 * | - |
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| MSB | Delayed | |
Tradegate
| LWB | Real-time | |
|
Boerse Muenchen
| LWB | Real-time | |
|
Börse Stuttgart
| LWB | Delayed | |
|
Deutsche Boerse AG
| LWB | Delayed | |
|
OTC Markets
| MEOBF | Delayed | |
|
Berne S.E.
| LWB | End-of-day quote |
Last Transcript: Mesoblast Limited
| 1 day | +0.98% | ||
| 1 week | -3.29% | ||
| Current month | -12.71% | ||
| 1 month | -16.26% | ||
| 3 months | +5.64% | ||
| 6 months | -3.74% | ||
| Current year | -24.26% |
| 1 week | 2.04 |  | 2.29 |
| 1 month | 2.01 | | 2.45 |
| Current year | 1.88 | | 3.31 |
| 1 year | 1.88 | | 3.31 |
| 3 years | 0.26 | | 3.37 |
| 5 years | 0.26 | | 3.37 |
| 10 years | 0.26 | | 5.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
Silviu Itescu
CEO | Chief Executive Officer | 69 | 2011-03-22 |
James O'Brien
DFI | Director of Finance/CFO | 59 | 2025-11-16 |
Teresa Montagut
CTO | Chief Tech/Sci/R&D Officer | - | 2026-03-10 |
| Director | Title | Age | Since |
|---|---|---|---|
Silviu Itescu
BRD | Director/Board Member | 69 | 2006-12-31 |
Eric Rose
BRD | Director/Board Member | 75 | 2013-04-14 |
William Burns
BRD | Director/Board Member | 78 | 2014-03-05 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/19/26 | Free | Director | 875,000 | 0.0674% | ||
| 7/17/26 | Exercice | Founder | 1,885,334 | 0.1456% | ||
| 7/17/26 | Exercice | Founder | -1,885,334 | 0.1456% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.47% | -3.29% | -14.88% | +442.11% | 1.97B | |
| +2.64% | +7.07% | +11.87% | +38.40% | 47.97B | |
| +0.22% | +1.71% | +50.91% | +34.00% | 44.5B | |
| -1.58% | +5.65% | +359.34% | +598.06% | 43.93B | |
| +1.70% | +4.61% | +12.56% | +90.97% | 41.03B | |
| +0.51% | -0.61% | +5.18% | +46.87% | 29.85B | |
| -0.48% | +0.59% | +23.98% | +148.36% | 17.27B | |
| +0.08% | +9.30% | +8.41% | - | 15.34B | |
| +1.76% | +2.98% | +29.13% | +45.78% | 15.3B | |
| +1.97% | -2.82% | - | - | 14.82B | |
| Average | +0.78% | +2.45% | +54.06% | +180.57% | 27.2B | |
| Weighted average by Cap. | +0.75% | +2.97% | +78.74% | +160.83% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 267M 187M 165M 156M 141M 265M 17.96B 1.86B 720M 9.16B 702M 687M 29.45B | 424M 297M 262M 247M 224M 421M 28.54B 2.96B 1.14B 14.57B 1.12B 1.09B 46.81B |
| Net income | -19.76M -13.87M -12.19M -11.53M -10.46M -19.64M -1.33B -138M -53.32M -679M -52.06M -50.93M -2.18B | 116M 81.06M 71.29M 67.42M 61.15M 115M 7.78B 807M 312M 3.97B 304M 298M 12.76B |
| Net Debt | 97.67M 68.55M 60.29M 57.01M 51.71M 97.11M 6.58B 683M 264M 3.36B 257M 252M 10.79B | 126M 88.13M 77.51M 73.3M 66.48M 125M 8.46B 878M 339M 4.32B 331M 324M 13.87B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-28 | A$2.070 | +1.47% | 49,497 |
| 26-09-28 | A$2.040 | -5.56% | 2,304,369 |
| 26-09-25 | A$2.160 | -1.37% | 1,402,530 |
| 26-09-24 | A$2.190 | +0.46% | 4,314,524 |
| 26-09-23 | A$2.180 | +0.93% | 1,760,354 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MSB Stock
Select your edition
All financial news and data tailored to specific country editions
